Rigetti Computing (RGTI) The High Cost of Catching a Quantum Wave

$600M Cash Runway, 1,000-Qubit Roadmap, But 609x P/S Demands Flawless Execution — HOLD | PT $14 | -10%

Investment Thesis

Rigetti Computing is a genuine quantum computing company — vertically integrated, technically credible, and sitting on $600M in cash with near-zero debt. The $250M Quanta Computer partnership, a growing hardware order pipeline (India C-DAC $8.4M, AFRL $5.8M), and a clear roadmap to 1,000+ qubits by 2027 make the long-term thesis compelling. We respect the technology. We do not dispute the TAM.

But the stock is priced as though the mission is already accomplished. At ~$5.4B market cap against TTM revenue of ~$7.5M, RGTI trades at 609x Price-to-Sales. Revenue has been declining — down 18.1% year-over-year in Q3 2025. Gross margins collapsed from 80% in Q1 2025 to just 21% in Q3 2025 due to a shift toward lower-margin development contracts. R&D spending ($49.8M in FY2024) is 4.6x total annual revenue. The market is pricing in quantum advantage that has not yet been demonstrated commercially.

We initiate with a HOLD and a 12-month price target of $14 (-10% from current $15.59). The stock is not a short — $600M in cash provides several years of runway and the Quanta partnership de-risks the near term. But it is also not a clear buy at these levels. The correct posture is patience: wait for Q1 2026 Cepheus delivery confirmation, C-DAC revenue recognition, and evidence that QCaaS growth is recovering before adding exposure. Investors already holding should continue to do so; new money should wait for a better entry.

Bull Case

• Cepheus (108-qubit) delivers Q1 2026 on-time, catalyzing enterprise interest and validating the roadmap
• India C-DAC $8.4M contract recognized as revenue in H1 2026, providing tangible proof of hardware monetization
• National Quantum Initiative (NQI) reauthorization expands government contract pipeline significantly
• Quanta partnership accelerates manufacturing scale, reducing per-unit cost and expanding hardware margins
• 150-qubit milestone reached ahead of schedule in 2026, triggering re-rating toward IonQ valuation levels

Bear Case

• Further Cepheus delays erode management credibility and trigger analyst downgrades
• QCaaS revenue continues to decline as cloud providers commoditize quantum access on AWS Braket and Azure
• NQI reauthorization stalls, removing a primary near-term revenue source
• Google or IBM achieves commercially relevant quantum advantage first, making superconducting peers irrelevant
• Cash burn rate accelerates from the Quanta collaboration R&D commitments, forcing dilutive equity raise before 2028

Sector Snapshot — Key Metrics

Quarterly Revenue Trend

Revenue volatility is the defining characteristic of RGTI financials. The company generates revenue from three streams: QCaaS subscriptions (shrinking — $356K in FY2024 vs $2.34M in FY2023), government development contracts (lumpy and milestone-dependent), and emerging hardware/QPU sales. Q3 2025 revenue of $1.95M was below consensus ($2.17M) and down 18.1% YoY, primarily due to the timing of NQI contract reauthorization. This is the fundamental near-term risk: a business that depends on government contract timing cannot deliver predictable quarterly growth.

Technology Roadmap — The Long Game

Rigetti operates Fab-1, its own wafer fabrication facility in Fremont, California — a critical differentiator that enables rapid iteration on quantum chip design without dependence on external foundries. This vertical integration is the technological moat. The Ankaa-3 system (84 qubits, 99.0% median two-qubit iSWAP gate fidelity) was a meaningful milestone: it halved error rates from the prior generation. The Cepheus platform (108-qubit, targeting Q1 2026) has been delayed once and represents the next critical proof point. The 1,000+ qubit target for 2027 would represent a genuine step toward commercially useful quantum advantage.

The Quanta Computer Collaboration Agreement (February 2025) is strategically significant. Quanta, a world-class electronics manufacturer, will develop control systems, dilution refrigerators, and non-QPU components for Rigetti systems — effectively outsourcing the hardest manufacturing scale challenge to a partner with the supply chain expertise to solve it. The $250M five-year commitment validates the technology and extends the runway.

Financial Overview

Competitive Benchmark

Rigetti leads among the pure-play public quantum names on tech leadership (Fab-1 vertical integration, superconducting gate fidelity roadmap) and balance sheet strength. However, it trails IonQ significantly on revenue scale and commercial traction — IonQ has demonstrated faster revenue growth (+221% YoY in Q3 2025) by converting enterprise clients like Hyundai and Airbus, while Rigetti remains concentrated in government/research customers. IBM's quantum division, while not a standalone public company, sets the competitive ceiling: 133-qubit systems, multi-billion dollar R&D budget, and full enterprise distribution.

Peer Comparison

Valuation & Price Target

Valuing RGTI requires setting aside conventional metrics. The P/S ratio of 609x and EV/Revenue of 1,170x are untethered from current fundamentals — they price in the possibility of commercial quantum advantage materializing at scale. We do not use these multiples to derive our target; instead, we anchor on scenario-weighted probability: 50% base case ($14, reflecting ~35x FY2026E consensus revenue of $21M), 25% bull ($25, based on hardware order acceleration and QCaaS recovery), and 25% bear ($5, reflecting multiple delivery delays and further revenue decline). Blended: $14.50 — rounded to our PT of $14.

The current price of $15.59 is within our base-case range. The stock is not obviously mis-valued in either direction — which is precisely why we rate it HOLD. The upside is real but requires flawless execution on the Cepheus delivery, C-DAC revenue recognition, and a favorable NQI reauthorization environment. Investors should demand catalysts before building a position at current prices.

Scenario Analysis

Key Catalysts (12-Month Horizon)

• Cepheus 108-qubit system delivery confirmation (Q1 2026 target) — the single most important near-term milestone
• India C-DAC $8.4M 108-qubit system revenue recognition — first large-scale hardware delivery
• National Quantum Initiative (NQI) Act reauthorization — unlocks government contract pipeline
• Quanta partnership first statement of work executed — tangible manufacturing scale progress
• Any new enterprise commercial customer announcement (non-government) — validates commercial traction thesis
• 100+ qubit system with 99.5% two-qubit fidelity — confirms roadmap execution and separates RGTI from peers
• Q4 2025 / Q1 2026 earnings: revenue stabilization or acceleration would re-rate the stock toward bull scenario

Key Risks

• Execution risk: Cepheus was already delayed once; any further slip severely damages management credibility
• Revenue concentration: government contracts are lumpy and NQI-dependent; any policy shift hits revenue immediately
• Competitive risk: IonQ is winning commercial accounts faster; Google and IBM have vastly superior R&D resources
• Valuation risk: at 609x P/S, any growth miss triggers disproportionate drawdowns — the stock is sentiment-driven
• Cash burn: ~$15-20M/quarter operationally; while $600M provides ample runway, capital recycling into manufacturing may accelerate burn
• Dilution risk: the ATM agreement with B. Riley and potential future equity raises will increase shares outstanding over time
• Gross margin collapse: from 80% in Q1 2025 to 21% in Q3 2025 — if the revenue mix continues shifting to low-margin development contracts, the business model becomes more capital-intensive

The Quanta Signal

Quanta Computer's commitment to invest $250M over five years alongside a $35M equity investment at $11.59/share (executed February 2025) is the most important strategic validation in Rigetti's history. Quanta is not a financial investor — it is one of the world's largest electronics ODMs, manufacturing for Apple, Amazon, Google, and others. When Quanta agrees to develop control systems and dilution refrigerators for Rigetti's quantum systems, it is effectively endorsing the superconducting quantum computing platform as commercially viable enough to justify manufacturing investment.

The practical impact: Rigetti gains access to supply chain expertise that would take years and hundreds of millions of dollars to build independently. The dilution refrigerators required for superconducting qubits (sourced from Oxford Instruments) are a supply chain bottleneck for the entire industry. Quanta's involvement in developing alternative, scalable refrigeration solutions could dramatically reduce Rigetti's per-system cost and delivery timelines — which, if executed, is the unlock for hardware revenue at meaningful scale.

Frequently Asked Questions

Why HOLD and not BUY given the $600M cash and Quanta partnership?

Because price matters. RGTI is trading at 609x trailing P/S. Even using forward estimates ($21M in FY2026), the stock is at 257x 2026 P/S. IonQ — a more commercially traction-rich peer — trades at ~170x 2026 P/S. The Quanta partnership and cash pile are already reflected in the stock price. The risk/reward at $15.59 is not asymmetric enough to justify a BUY. A pullback toward $10-12 would change that calculus.

Is declining revenue a company problem or a government timing problem?

Both. Management has been transparent that the NQI reauthorization delay is the primary near-term headwind for government contract revenue. That is an exogenous factor. But the structural decline in QCaaS revenue ($356K in FY2024 vs $3.19M in FY2022) reflects a genuine market challenge: cloud customers can access quantum hardware through AWS Braket and Azure without committing to Rigetti specifically. The hardware sales model (Novera, Cepheus) is the right strategic pivot, but it is early and lumpy.

What would make us upgrade to BUY?

Three things: (1) Cepheus delivers Q1 2026 on-time and C-DAC revenue recognized; (2) FY2026 revenue tracking shows trajectory toward $21M+ consensus; (3) gross margins recover toward 50%+ as hardware mix improves. If all three materialize by mid-2026, the stock merits a re-rating toward the bull case and an upgrade. Until then, we watch from the sidelines.

Verdict — HOLD | PT $14 | -10%

Rigetti Computing is a company building something real, in a market that matters, with enough cash to see it through. CEO Dr. Subodh Kulkarni brings 30 years of semiconductor manufacturing experience — the single most relevant skillset for a company whose competitive advantage lives inside Fab-1. The Quanta deal is transformative in the manufacturing dimension. The 1,000-qubit roadmap is ambitious but not unreasonable.

The problem is the stock. At $15.59 and a $5.4B market cap, investors are paying now for outcomes that, by management's own guidance, are 3-5 years away in terms of meaningful commercial scale. Revenue is declining. Margins are compressing. The quantum market remains in its "emerging quantum advantage" phase. Betting on RGTI today requires believing that the technology will work, the market will materialize, and Rigetti will outcompete IBM, Google, and IonQ — all simultaneously.

We rate RGTI HOLD with a price target of $14 (-10%). The stock is neither cheap enough to buy nor broken enough to sell. Watch Cepheus. Watch C-DAC revenue. Watch gross margin recovery. The next 6 months will tell us whether the bull case is on track or the bear case is quietly setting in. Be ready to act either way.

DISCLAIMER: This report is produced by Edgen Research for informational purposes only and does not constitute investment advice. Data sourced from: Rigetti 10-K (FY2024, filed March 2025), Rigetti 10-Q (Q3 2025, filed November 2025), and 360 Research (February 19, 2026). Price data as of February 17, 2026. Past performance is not indicative of future results. Edgen Research and its affiliates may hold positions in securities mentioned.

Edgen Research · Published: March 19, 2026 · Analyst: Edgen AI Platform